Phase I trial of daily imatinib mesylate and weekly paclitaxel in patients with advanced refractory solid tumors

被引：0
|
作者：
Bahrani, A [1 ]
Hwang, J [1 ]
Malik, S [1 ]
Marshall, JL [1 ]
机构：
[1] Georgetown Univ Hosp, Washington, DC 20007 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3087
引用
收藏
页码：216S / 216S
页数：1
相关论文
共 50 条
  • [41] Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
    Stathis, A.
    Hess, D.
    von Moos, R.
    Homicsko, K.
    Griguolo, G.
    Joerger, M.
    Mark, M.
    Ackermann, C. J.
    Allegrini, S.
    Catapano, C. V.
    Xyrafas, A.
    Enoiu, M.
    Berardi, S.
    Gargiulo, P.
    Sessa, C.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 766 - 772
  • [42] Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours
    Androulakis, N
    Kouroussis, C
    Mavroudis, D
    Kakolyris, S
    Souglakos, J
    Agelaki, S
    Kalbakis, K
    Malas, K
    Pallis, A
    Samonis, G
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (15) : 1992 - 1997
  • [43] A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors
    Cohen, Adam L.
    Ray, Abhijit
    Van Brocklin, Matthew
    Burnett, David M.
    Bowen, Randy C.
    Dyess, Donna L.
    Butler, Thomas W.
    Dumlao, Theresa
    Khong, Hung T.
    ONCOTARGET, 2017, 8 (32) : 52413 - 52419
  • [44] Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies
    Monica Mita
    Alain Mita
    John Sarantopoulos
    Chris H. Takimoto
    Eric K. Rowinsky
    Ofelia Romero
    Patrizia Angiuli
    Cecilia Allievi
    Amy Eisenfeld
    Claire F. Verschraegen
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 287 - 295
  • [45] A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors
    Gouda, M. A.
    Shunyakova, J.
    Naing, A.
    Dumbrava, E.
    Hong, D. S.
    Yuan, Y.
    Yang, P.
    Myers, A.
    Liang, Y.
    Peng, J.
    Karp, D.
    Tsimberidou, A. M.
    Rodon, J.
    Yap, T. A.
    Piha-Paul, S. A.
    Meric-Bernstam, F.
    Fu, S.
    ESMO OPEN, 2024, 9 (06)
  • [46] Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer
    Tew, William P.
    Radovich, Delia
    O'Reilly, Eileen
    Schwartz, Gary
    Schrag, Deborah
    Saltz, Leonard B.
    Kelsen, David P.
    Kepler, Stacey
    Ilson, David H.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (04) : 366 - 373
  • [47] Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer
    William P. Tew
    Delia Radovich
    Eileen O’Reilly
    Gary Schwartz
    Deborah Schrag
    Leonard B. Saltz
    David P. Kelsen
    Stacey Kepler
    David H. Ilson
    Investigational New Drugs, 2009, 27 : 366 - 373
  • [48] Phase II trial of weekly paclitaxel in patients with advanced melanoma
    Walker, L
    Schalch, H
    King, DM
    Dietrich, L
    Eastman, M
    Kwak, M
    Kim, K
    Albertini, MR
    MELANOMA RESEARCH, 2005, 15 (05) : 453 - 459
  • [49] Phase I trial of combination nab-paclitaxel and pemetrexed in advanced solid tumors
    Ho, C.
    Davies, A. M.
    Lara, P. N.
    Chew, H. K.
    Beckett, L.
    Sangha, R. S.
    Mack, P. C.
    Gandara, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours
    Suder, A.
    Ang, J. E.
    Kyle, F.
    Harris, D.
    Rudman, S.
    Kristeleit, R.
    Solca, F.
    Uttenreuther-Fischer, M.
    Pemberton, K.
    Pelling, K.
    Schnell, D.
    de Bono, J.
    Spicer, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (16) : 2275 - 2284
12345